Regencell Bioscience Holdings Ltd. (RGC): Price and Financial Metrics

Regencell Bioscience Holdings Ltd. (RGC): $6.40

0.14 (-2.14%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

RGC Price/Volume Stats

Current price $6.40 52-week high $31.30
Prev. close $6.54 52-week low $6.39
Day low $6.40 Volume 558
Day high $6.40 Avg. volume 1,133
50-day MA $9.69 Dividend yield N/A
200-day MA $19.30 Market Cap 83.28M

RGC Stock Price Chart Interactive Chart >


Regencell Bioscience Holdings Ltd. (RGC) Company Bio


Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.


RGC Latest News Stream


Event/Time News Detail
Loading, please wait...

RGC Latest Social Stream


Loading social stream, please wait...

View Full RGC Social Stream

Latest RGC News From Around the Web

Below are the latest news stories about REGENCELL BIOSCIENCE HOLDINGS LTD that investors may wish to consider to help them evaluate RGC as an investment opportunity.

15 Developed Countries with Lowest Autism Rates

In this article, we will discuss 15 developed countries with lowest autism rates. If you want to skip our discussion on the autism industry, you can go directly to the 5 Developed Countries with Lowest Autism Rates. According to Fortune Business Insights, the autism spectrum disorder market was assessed at $1.93 billion in 2022. The […]

Yahoo | November 15, 2023

Regencell Bioscience Holdings (NASDAQ:RGC) Is In A Good Position To Deliver On Growth Plans

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Yahoo | October 29, 2023

With 81% ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders have a lot riding on the company's future

Key Insights Regencell Bioscience Holdings' significant insider ownership suggests inherent interests in company's...

Yahoo | July 31, 2023

One Regencell Bioscience Holdings Limited (NASDAQ:RGC) insider upped their stake by 0.5% in the previous year

Looking at Regencell Bioscience Holdings Limited's ( NASDAQ:RGC ) insider transactions over the last year, we can see...

Yahoo | April 3, 2023

Read More 'RGC' Stories Here

RGC Price Returns

1-mo N/A
3-mo -39.05%
6-mo N/A
1-year -75.60%
3-year N/A
5-year N/A
YTD -39.05%
2023 N/A
2022 0.00%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!